Related Experiment Videos
Immigration presents a potential increased risk for atherosclerosis
Scott A Lear1, Karin H Humphries, Samantha Hage-Moussa
1Simon Fraser University, British Columbia, Canada. slear@providencehealth.bc.ca
Atherosclerosis
|February 3, 2009
Summary
Longer time since immigration is linked to increased sub-clinical atherosclerosis in immigrants. This cardiovascular disease risk factor grows over time, independent of other factors, highlighting immigrants as a high-risk group.
Area of Science:
- Cardiovascular epidemiology
- Public health
- Immigrant health
Background:
- Western immigrants often face higher cardiovascular disease (CVD) risk than in their home countries.
- It remains unclear if immigrant CVD risk exceeds that of non-immigrants in host countries.
Purpose of the Study:
- To investigate the independent association between time since immigration and sub-clinical atherosclerosis.
- To assess atherosclerosis burden in immigrants of Chinese, European, and South Asian origin compared to non-immigrants.
Main Methods:
- A cross-sectional study involving 460 immigrants and 158 non-immigrants across three ethnicities.
- Sub-clinical atherosclerosis assessed via carotid artery ultrasound (intima-media thickness, plaque area).
- Data collected on socio-demographics, CVD risk factors, lifestyle, and time since immigration.
Main Results:
- Immigrants residing in the host country for >=30 years showed greater carotid intima-media thickness (IMT) than non-immigrants and recent immigrants (< or =20 years).
- Time since immigration significantly correlated with IMT, plaque area, and combined IMT+plaque area.
- Adjusted analysis confirmed time since immigration as an independent predictor of increased IMT (2% per decade), alongside age (7% per decade).
Conclusions:
- Immigration is associated with a higher burden of sub-clinical atherosclerosis compared to non-immigrants.
- This atherosclerosis burden escalates with longer duration of stay, irrespective of other known risk factors.
- Immigrants constitute a vulnerable population requiring targeted cardiovascular interventions.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...